Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cells

Bioinformatics

Volumn 24, Issue 16, 2008, Pages 1745-1748

  Li, Meng ^a,b,c   Paik, Hyun Il Henry ^a   Balch, Curt ^a,d   Kim, Yoosung ^e   Li, Lang ^d   Huang, Tim H M ^f   Nephew, Kenneth P ^a,b,d   Kim, Sun ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d INDIANA UNIVERSITY   (United States)

^e Inha University   (South Korea)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSCRIPTION FACTOR;

BINDING SITE; BIOINFORMATICS; CANCER CELL CULTURE; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENETIC DATABASE; GENOME ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 49549109411     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btn256     Document Type: Conference Paper

References (26)

1. Agarwal,R. and Kaye,S.B. (2003) Ovarian cancer: Strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer, 3, 502-516.
2. American Cancer Society: Key statistics about ovarian cancer (2008). Available at: http://www.cancer.org
3. Balch,C. et al. (2004) The epigenetics of ovarian cancer drug resistance and resensitization. Am. J. Obstet. Gynecol., 191 1552-1572.
4. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc., Ser. B., 57, 289-20.
5. Bird,A. (1992) The essentials of DNA methylation. Cell, 70, 5-8.
6. Bock,C. et al. (2006) CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats and predicted DNA structure. PLoS Genet., 2, e26.
7. Bock,C. et al. (2007) CpG island mapping by epigenome prediction. PLoS Comput. Biol, 3, e110.
8. Cable,P.L. et al. (2003) Novel consensus DNA-binding sequence for BRCA1 protein complexes Mol. Carcinog., 38, 85-96.
9. Chiang,J.W. et al. (2006) BRCA1 promoter methylation predicts adverse ovarian cancer prognosis Gynecol Oncol., 101, 403-410.
10. Das,R. et al. (2006) Computational prediction of methylation status in human genomic sequences. Proc. Natl. Acad. Sci. USA, 103, 10713-10716.
11. Fan,M. et al. (2006) Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res., 66 11954-11966.
12. Fang,F. et al. (2006) Predicting methylation status of CpG islands in the human brain. Bioinformatics, 22, 2204-2209.
13. Goh,L. et al. (2007) Genomic sweeping for hypermethylated genes. Bioinformatics, 23, 281-288.
14. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-28.
15. Jung,S.H. et al. (2005) Sample size calculation for multiple testing in microarray data analysis. Biostatistics, 6, 157-169.
16. Kel,A.E. et al. (2003) MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res., 31 3576-3579.
17. Keshet,I. et al. (2006) Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet., 38, 149-153.
18. Leu,Y.W. et al. (2004) Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res., 64, 8184-8192.
19. Ozols,R.F. (2005) Treatment goals in ovarian cancer. Int. J. Gynecol. Cancer, 15 (Suppl 1.), 3-11.
20. Perez,R.P., et al. (1993) Mechanisms and modulation of resistance to chemotherapy in ovarian cancer. Cancer, 71, 1571-1580.
21. Siddik,Z.H. (2003) Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene, 22, 7265-7279.
22. Tada,Y. et al. (2006) Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J. Natl. Cancer Inst., 98, 396-406.
23. Taylor,K.H. et al. (2007) Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia Cancer Res., 67, 2617-2625.
24. Wei,S.H. et al. (2002) Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin. Cancer Res., 8, 2246-2252.
25. Wei,S.H. et al. (2006) Prognostic DNA methylation biomarkers in ovarian cancer. Clin. Cancer Res., 12, 2788-2794.
26. Zhang,P. et al. (2004) CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer. Mol. Cancer, 3, 14.